Skip to main content
Clinical Trials/NL-OMON28080
NL-OMON28080
Recruiting
Not Applicable

Schema therapy as treatment for adults with autism spectrum disorder and comorbid personality disorder: a multiple baseline case series study testing cognitive-behavioral and experiential interventions.

Sarr expertise centre for autism (part of Parnassia group)Oudedijk 763062 AG RotterdamThe Netherlands0 sites12 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
schema therapy, adults, autism spectrum disorder, personality disorder, cognitive-behavioral, experientialschematherapie, volwassenen, autismespectrumstoornis, persoonlijkheidsstoornis, cognitief gedragstherapeutisch, experientieel
Sponsor
Sarr expertise centre for autism (part of Parnassia group)Oudedijk 763062 AG RotterdamThe Netherlands
Enrollment
12
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Sarr expertise centre for autism (part of Parnassia group)Oudedijk 763062 AG RotterdamThe Netherlands

Eligibility Criteria

Inclusion Criteria

  • Inclusion criteria are a primary diagnosis of DSM\-IV and/or DSM\-5 autism spectrum disorder and personality disorder, age 18\-65 years, with IQ at least normal intelligent (IQ \> 80\), at least a completed primary school and secondary education, having a reasonable degree of insight into their own personality and recognition of their (psychological) functioning, and a willingness to participate in the study for 2 years confirmed by a signed informed consent.

Exclusion Criteria

  • Exclusion criteria are schizophrenia or other psychotic disorder, antisocial PD, eating disorder, psychiatric disorders secondary to medical conditions, mental retardation (IQ \< 80\), addiction (that needs clinical detox) and presence of current suicidal ideation. Participants are not allowed to follow another concurrent psychological treatment at the same time. Pharmacotherapy can be used as a co\-intervention during the treatment when already started before the study intervention. This is no reason for exclusion from the study. When participants have to start with pharmacotherapy or another form of (support) therapy during the study intervention, for example in case of acute crisis, this will not lead to exclusion from the study, only when this therapy and the results will be documented precisely.

Outcomes

Primary Outcomes

Not specified

Similar Trials